LUPIN
Back to All Ratios
|
LUPIN Last 5 Year EV/Net Sales History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EV/Net Sales(x) | 4.16 | 3.76 | 1.95 | 2.23 | 3.26 |
What is the latest EV/Net Sales ratio of LUPIN ?
Year | EV/Net Sales |
---|---|
Mar2025 | 4.16 |
Mar2024 | 3.76 |
Mar2023 | 1.95 |
Mar2022 | 2.23 |
Mar2021 | 3.26 |
How is EV/Net Sales of LUPIN Trending?
Years | EV/Net Sales | % Change | |
---|---|---|---|
Mar2025 | 4.16 | 10.64 | |
Mar2024 | 3.76 | 92.82 | |
Mar2023 | 1.95 | -12.56 | |
Mar2022 | 2.23 | -31.60 | |
Mar2021 | 3.26 | - |
Other Financial Ratios of LUPIN
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Net Sales ratio of peers of LUPIN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LUPIN | ₹90,003.3 Cr | 2.4% | -0.9% | -14.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,329.0 Cr | 0.9% | 3.7% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,991.0 Cr | 7.4% | 9% | 8.2% | Stock Analytics | |
CIPLA | ₹126,326.0 Cr | 3.3% | 0.2% | -7.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,126.0 Cr | -0.7% | -1.7% | -0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,324.0 Cr | 1% | -3.2% | -5.2% | Stock Analytics |
LUPIN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LUPIN | 2.4% |
-0.9% |
-14.2% |
SENSEX | 0.7% |
1.1% |
0.9% |
You may also like the below Video Courses